Colicin insensitivity correlates with a higher prevalence of extraintestinal virulence factors among Escherichia coli isolates from skin and soft-tissue infections

References

1. Arnold T., Zeth K., Linke D. 2009; Structure and function of colicin S4, a colicin with a duplicated receptor-binding domain. J Biol Chem 284:6403–6413 [View Article][PubMed]
   [Google Scholar]
2. Cascales E., Buchanan S. K., Duché D., Kleanthous C., Lloubès R., Postle K., Riley M., Slatin S., Cavard D. 2007; Colicin biology. Microbiol Mol Biol Rev 71:158–229 [View Article][PubMed]
   [Google Scholar]
3. Feldgarden M., Riley M. A. 1998; High levels of colicin resistance in Escherichia coli . Evolution 52:1270–1276 [View Article]
   [Google Scholar]
4. Gillor O., Kirkup B. C., Riley M. A. 2004; Colicins and microcins: the next generation antimicrobials. In Advances in Applied Microbiology pp. 129–146 Edited by Allen J. W. B., Laskin I., Geoffrey M. G. London/San Diego: Academic Press; [View Article]
   [Google Scholar]
5. Horcajada J. P., Soto S., Gajewski A., Smithson A., Jiménez de Anta M. T., Mensa J., Vila J., Johnson J. R. 2005; Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 43:2962–2964 [View Article][PubMed]
   [Google Scholar]
6. Johnson J. R., Stamm W. E. 1989; Urinary tract infections in women: diagnosis and treatment. Ann Intern Med 111:906–917[PubMed] [CrossRef]
   [Google Scholar]
7. Johnson J. R., Gajewski A., Lesse A. J., Russo T. A. 2003; Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J Clin Microbiol 41:5798–5802 [CrossRef]
   [Google Scholar]
8. Johnson J. R., Kuskowski M. A., O’bryan T. T., Colodner R., Raz R. 2005; Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother 49:26–31 [View Article][PubMed]
   [Google Scholar]
9. Johnson J. R., Johnston B., Clabots C., Kuskowski M. A., Castanheira M. 2010; Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51:286–294 [View Article][PubMed]
   [Google Scholar]
10. Marrs C. F., Zhang L., Foxman B. 2005; Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?. FEMS Microbiol Lett 252:183–190 [View Article][PubMed]
    [Google Scholar]
11. Masi M., Vuong P., Humbard M., Malone K., Misra R. 2007; Initial steps of colicin E1 import across the outer membrane of Escherichia coli . J Bacteriol 189:2667–2676 [View Article][PubMed]
    [Google Scholar]
12. Moet G. J., Jones R. N., Biedenbach D. J., Stilwell M. G., Fritsche T. R. 2007; Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis 57:7–13 [View Article][PubMed]
    [Google Scholar]
13. Nowrouzian F., Adlerberth I., Wold A. E. 2001; P fimbriae, capsule and aerobactin characterize colonic resident Escherichia coli . Epidemiol Infect 126:11–18 [View Article][PubMed]
    [Google Scholar]
14. Nowrouzian F., Hesselmar B., Saalman R., Strannegard I. L., Aberg N., Wold A. E., Adlerberth I. 2003; Escherichia coli in infants’ intestinal microflora: colonization rate, strain turnover, and virulence gene carriage. Pediatr Res 54:8–14 [View Article][PubMed]
    [Google Scholar]
15. Obata-Yasuoka M., Ba-Thein W., Tsukamoto T., Yoshikawa H., Hayashi H. 2002; Vaginal Escherichia coli share common virulence factor profiles, serotypes and phylogeny with other extraintestinal E. coli. . Microbiology 148:2745–2752
    [Google Scholar]
16. Oelschlaeger T. A., Dobrindt U., Hacker J. 2002; Virulence factors of uropathogens. Curr Opin Urol 12:33–38 [View Article][PubMed]
    [Google Scholar]
17. Olesen B., Scheutz F., Menard M., Skov M. N., Kolmos H. J., Kuskowski M. A., Johnson J. R. 2009; Three-decade epidemiological analysis of Escherichia coli O15 : K52 : H1. J Clin Microbiol 47:1857–1862 [View Article][PubMed]
    [Google Scholar]
18. Parret A. H. A., De Mot R. 2002; Escherichia coli’s uropathogenic-specific protein: a bacteriocin promoting infectivity?. Microbiology 148:1604–1606[PubMed]
    [Google Scholar]
19. Petkovšek Ž., Eleršič K., Gubina M., Žgur-Bertok D., Starčič Erjavec M. 2009; Virulence potential of Escherichia coli isolates from skin and soft tissue infections. J Clin Microbiol 47:1811–1817 [View Article][PubMed]
    [Google Scholar]
20. Picard B., Garcia J. S., Gouriou S., Duriez P., Brahimi N., Bingen E., Elion J., Denamur E. 1999; The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67:546–553[PubMed]
    [Google Scholar]
21. Pugsley A. P. 1985; Escherichia coli K12 strains for use in the identification and characterization of colicins. J Gen Microbiol 131:369–376[PubMed]
    [Google Scholar]
22. Rijavec M. 2010; Virulence factors of uroseptic Escherichia coli strains and possible use of colicins as new antimicrobials against urinary infections. PhD thesis, University of Ljubljana, Ljubljana, Slovenia.
    [Google Scholar]
23. Rijavec M., Budič M., Mrak P., Müller-Premru M., Podlesek Z., Žgur-Bertok D. 2007; Prevalence of ColE1-like plasmids and colicin K production among uropathogenic Escherichia coli strains and quantification of inhibitory activity of colicin K. Appl Environ Microbiol 73:1029–1032 [View Article][PubMed]
    [Google Scholar]
24. Riley M. A., Gordon D. M. 1992; A survey of Col plasmids in natural isolates of Escherichia coli and an investigation into the stability of Col-plasmid lineages. J Gen Microbiol 138:1345–1352[PubMed] [CrossRef]
    [Google Scholar]
25. Russo T. A., Johnson J. R. 2000; Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 181:1753–1754 [View Article][PubMed]
    [Google Scholar]
26. Russo T. A., Johnson J. R. 2006; Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development. Expert Rev Vaccines 5:45–54 [View Article][PubMed]
    [Google Scholar]
27. Schamberger G. P., Phillips R. L., Jacobs J. L., Diez-Gonzalez F. 2004; Reduction of Escherichia coli O157 : H7 populations in cattle by addition of colicin E7-producing E. coli to feed. Appl Environ Microbiol 70:6053–6060 [View Article][PubMed]
    [Google Scholar]
28. Stahl C. H., Callaway T. R., Lincoln L. M., Lonergan S. M., Genovese K. J. 2004; Inhibitory activities of colicins against Escherichia coli strains responsible for postweaning diarrhea and edema disease in swine. Antimicrob Agents Chemother 48:3119–3121 [View Article][PubMed]
    [Google Scholar]
29. Starčič Erjavec M., Rijavec M., Križan-Hergouth V., Fruth A., Žgur-Bertok D. 2007; Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential. Int J Antimicrob Agents 30:436–442 [View Article][PubMed]
    [Google Scholar]
30. Zhang L., Foxman B. 2003; Molecular epidemiology of Escherichia coli mediated urinary tract infections. Front Biosci 8:e235–e244 [View Article][PubMed]
    [Google Scholar]